Abbott Laboratories (NYSE:ABT) is one of the best 52-week low blue-chip stocks to buy right now. Reuters reported on February ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on the ABT stock here.

Feb 4 (Reuters) - Medical device maker Abbott Laboratories has reported 860 serious injuries linked to the recall of some of ...

Abbott Laboratories today announced the successful completion of a multi-country diagnostic market development and professional training initiative across Latin America, delivering measurable ...

Abbott Labs stock hit a 52-week low after an earnings miss, but CEO Robert Ford isn't flinching. Here is why his $2 million ...

ABT, is repositioning its business after ongoing challenges in its Nutrition segment. The company is advancing a major acquisition of Exact Sciences to expand into oncology diagnostics. Management is ...

Over the last year, a good number of insiders have significantly increased their holdings in Abbott Laboratories . This is ...

San Clemente-based cardiac device company AtaCor Medical announced a collaboration with Abbott Laboratories to develop a next ...

The company reported quarterly sales of $11.46 billion, slightly missing the consensus of $11.80 billion. Sales increased 4.4% on a reported basis, 3% on an organic basis, or 3.8% when excluding COVID ...

Abbott Laboratories ( ABT) Q4 2025 Earnings Call January 22, 2026 9:00 AM EST Good morning, and thank you for standing by. Welcome to Abbott's Fourth Quarter 2025 Earnings Conference Call. [Operator ...

By Saurabh Sharma and Arpan Chaturvedi GHAZIABAD, India, Jan 23 (Reuters) - Indian drugmaker Abbott Healthcare's supply chain is being scrutinised as part of a wider investigation into the alleged ...